Group 1 - The lawsuit is currently in the retrial phase, with the company as the plaintiff and the amount involved being 10,340,829 yuan [2] - The company has previously made full provisions for bad debts related to the advance payment to Hosheng Medical, and it plans to appeal the recent judgment [2][6] - The recent judgment from Huangpu Court has ruled to terminate the nine mold procurement contracts and rejected all claims from Hosheng Medical [4] Group 2 - The company has incurred litigation costs of 87,131.24 yuan for the main case and 41,922.49 yuan for the counterclaim, with additional costs for litigation preservation [4] - The company is unable to predict the impact of the recent judgment on its current and future profits [6] - The company will continue to monitor the case's progress and fulfill its information disclosure obligations [6]
广州洁特生物过滤股份有限公司 关于公司诉讼事项重审一审判决的进展公告